Using breakthrough microcatheter technology, iTrack™ is a highly effective MIGS device that does not remove or damage tissue and does not require a permanent stent or shunt.
Despite measuring just 250 µm in diameter, the iTrack™ canaloplasty microcatheter comprises an infusion pathway, a proprietary guide-wire that controls how the microcatheter tracks, and a fiber optic for illuminating the distal tip.
Rather than attempt to mechanically change or bypass the pathway of aqueous outflow, iTrack™ acts to re-establish the natural outflow pathway via a two-step process of microcatheterization and viscodilation. Watch our clinical videos to see how.
Introduced in 2008 and with more than 150,000 procedures performed globally, there is extensive clinical literature attesting to the efficacy and safety profile of iTrack™ in the treatment of glaucoma. Browse the online bibliography.